Description

Imfinzi is a monoclonal antibody used in cancer treatment, specifically for patients with unresectable stage III non-small cell lung cancer. It works by targeting the PD-L1 protein, helping to enhance the immune response against cancer cells.

Interpreter Notes

Interpreters should be aware that 'Imfinzi' may be referred to in various ways, such as 'durvalumab' in clinical discussions. It is important to maintain a formal register and ensure that the context of use is clear, especially in oncology settings.

Example Sentences

EN: The oncologist recommended Imfinzi as a treatment option for the patient's lung cancer.

ES: El oncólogo recomendó Imfinzi como una opción de tratamiento para el cáncer de pulmón del paciente.

Common Interpreter Mistakes

Confusing Imfinzi with other cancer medications; mispronouncing 'Imfinzi' as if it were a common word; failing to recognize its specific application in non-small cell lung cancer.